MUSTANG BIO INC's ticker is MBIO and the CUSIP is 62818Q104. A total of 80 filers reported holding MUSTANG BIO INC in Q3 2020. The put-call ratio across all filers is 2.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $38,000 | -45.7% | 37,511 | -11.2% | 0.00% | – |
| Q4 2021 | $70,000 | -35.2% | 42,219 | +5.5% | 0.00% | – |
| Q3 2021 | $108,000 | -21.2% | 40,035 | -3.1% | 0.00% | – |
| Q2 2021 | $137,000 | +25.7% | 41,319 | +25.2% | 0.00% | – |
| Q1 2021 | $109,000 | -20.4% | 33,001 | -8.5% | 0.00% | – |
| Q4 2020 | $137,000 | +185.4% | 36,069 | +135.4% | 0.00% | – |
| Q3 2020 | $48,000 | +9.1% | 15,321 | +10.0% | 0.00% | – |
| Q2 2020 | $44,000 | +76.0% | 13,931 | +48.0% | 0.00% | – |
| Q1 2020 | $25,000 | -37.5% | 9,413 | -5.7% | 0.00% | – |
| Q4 2019 | $40,000 | +60.0% | 9,981 | +23.7% | 0.00% | – |
| Q3 2019 | $25,000 | -62.1% | 8,069 | -56.0% | 0.00% | – |
| Q2 2019 | $66,000 | -4.3% | 18,348 | -11.0% | 0.00% | – |
| Q1 2019 | $69,000 | +13.1% | 20,626 | -3.0% | 0.00% | – |
| Q4 2018 | $61,000 | -85.5% | 21,271 | -70.1% | 0.00% | – |
| Q3 2018 | $422,000 | +5.2% | 71,105 | +21.5% | 0.00% | – |
| Q2 2018 | $401,000 | – | 58,524 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 297,500 | $300,000 | 0.47% |
| GSA CAPITAL PARTNERS LLP | 1,216,445 | $1,229,000 | 0.16% |
| Ikarian Capital, LLC | 546,824 | $551,000 | 0.07% |
| Sassicaia Capital Advisers LLC | 12,000 | $12,000 | 0.06% |
| EMFO, LLC | 32,000 | $32,000 | 0.03% |
| B. Riley Wealth Advisors, Inc. | 310,926 | $315,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 312,800 | $316,000 | 0.01% |
| Renaissance Technologies | 2,449,100 | $2,474,000 | 0.00% |
| Arete Wealth Advisors, LLC | 15,538 | $16,000 | 0.00% |
| Herold Advisors, Inc. | 4,000 | $4,040,000 | 0.00% |